Skip to main content

Table 3 Potential adverse events and selected laboratory valuesa

From: Corticosteroid therapy in refractory shock following cardiac arrest: a randomized, double-blind, placebo-controlled, trial

 

Hydrocortisone (n = 25)

Placebo (n = 25)

p value

Adverse event after study drug

   

 Any bleeding

5 (20 %)

2 (9 %)

0.42

 New or changed antibiotics

9 (36 %)

11 (44 %)

0.77

 New insulin infusion

7 (28 %)

6 (24 %)

1.00

Laboratory values

   

 Glucose level (mg/dL)

   

  6 hour

242 (151)

230 (118)

0.76

  24 hour

218 (109)

199 (90)

0.54

  48 hour

163 (50)

155 (59)

0.66

  72 hour

150 (52)

144 (61)

0.79

 Sodium level (mmol/L)

   

  6 hour

139 (5)

139 (6)

0.78

  24 hour

139 (5)

138 (5)

0.37

  48 hour

139 (7)

139 (5)

0.80

  72 hour

143 (6)

139 (8)

0.09

 White blood count (x 103)

   

  6 hour

15.0 (6.9)

17.0 (6.7)

0.43

  24 hour

17.8 (8.7)

15.5 (4.7)

0.29

  48 hour

21.5 (9.3)

12.6 (3.4)

<0.001

  72 hour

19.2 (8.8)

11.9 (2.9)

0.005

  1. aCategorical variables are presented as count (frequency) and continues variables as mean (standard deviation)